ArticlePloS one2024

Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.

Meiwen Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.